Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

50.63 +0.71 (+1.43%)
Streaming Delayed Price Updated: 3:58 PM EDT, May 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
87 88 Next >
Europe's CHMP Backs Pfizer/BioNTech's COVID-19 Shot For Kids Aged 5-11 Years
The European Medicines Agency's (EMA) human medicines committee (CHMP) recommended using Pfizer Inc (NYSE: PFE) - BioNTech SE's (NASDAQ: BNTX)... 
Via Benzinga
Exposures COVID-19
Pfizer Sues Former Employee For Stealing Confidential Info On Its Megablockbuster COVID-19 Vaccine
Pfizer Inc (NYSE: PFE) has sued its former associate director of clinical statistics in a California court to get a handle on allegedly stolen information. The Company's... 
Via Benzinga
Topics Lawsuit
Exposures COVID-19 Financial Legal
Johnson & Johnson's COVID-19 Shot Wins Its First Full Approval In Canada
Canada has become the first country to fully approve Johnson & Johnson's (NYSE: JNJ) single-dose Covid-19 vaccine. According to a statement, regulators... 
Via Benzinga
Exposures COVID-19
Big Data in the Healthcare & Pharmaceutical Market Is Going to Boom : Bayer, Pfizer, Novartis
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Big Data in the... 
Via SBWire
Pfizer Whale Trades Spotted
Someone with a lot of money to spend has taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on... 
Via Benzinga
Got $5,000? 2 Stocks to Buy and Hold Forever
The need for life-saving drugs won't subside anytime soon -- and that's what Pfizer and Eli Lilly provide. 
Via The Motley Fool
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Pfizer Posts Vupanorsen Data From Mid-Stage Cardiovascular Disease Trial
Pfizer Inc (NYSE: PFE) has provided an update on the Phase 2b study of vupanorsen, investigational antisense therapy for cardiovascular (CV) risk reduction and severe... 
Via Benzinga
Jim Cramer Shares His Thoughts On Verizon, Pfizer And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Verizon Communications Inc. (NYSE: 
Via Benzinga
How This News May Represent a Crucial Test for Moderna and Pfizer
It may determine the future of vaccine sales. 
Via The Motley Fool
Exposures COVID-19
3 Mega-Cap Healthcare Stocks to Buy for the Rest of the Year
Healthcare has long been considered a defensive sector that provides consistent returns to investors. 
Via Talk Markets
How AI Is Reducing The Costly Toll Of Cancer Drug Development And Disrupting The BioPharma Space
Bio-pharmaceutical investors know full well the drug discovery and development can be a long and uncertain process. Nowhere is that more true than in cancer drugs. This review looks at the history and... 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tuesday Markets Coverage
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears. 
Via Talk Markets
Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst
Pfizer, Inc. (NYSE:PFE) found huge success with its COVID-19 ... 
Via Benzinga
Exposures COVID-19
4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock
There's more to it than being the first to market with its vaccine. 
Via The Motley Fool
Exposures COVID-19
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG... 
Via Benzinga
Why FDA Boosters Authorization Could Be More Important for Pfizer and Moderna Than You Might Think
These might not be the only boosters that the FDA ultimately endorses. 
Via The Motley Fool
Exposures COVID-19 Product Safety
Biotech Stocks are Due for a Rally
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums. 
Via Talk Markets
Detecting Early Cancer Screening Stocks At An Early Stage Is Critical
If you're going to get cancer, you’re going to want to detect it early. While we’ve come a long way, baby, when it comes to treating terrible maladies like lung... 
Via Benzinga
How Alnylam Pharmaceuticals Could Take On Pfizer With A 'Catalyst-Rich' 2022
Alnylam is working on a drug that could tackle transthyretin cardiomyopathy. 
Via Investor's Business Daily
EU Says Decision On J&J COVID-19 Booster Shot Expected 'Within Weeks'
The European Medicines Agency (EMA) said it was evaluating data on booster doses of the COVID-19 vaccine by Johnson & Johnson (NYSE: JNJ). The CHMP will recommend... 
Via Benzinga
Exposures COVID-19
Why Moderna Stock Is Rising Today
Investors appear to like several developments related to its COVID-19 booster shots. 
Via The Motley Fool
Exposures COVID-19
3 Falling-Star Stocks to Buy Into the Holidays
Sentiment on Wall Street is not great but it is still proper to seek stocks to buy. Today's bunch are fallen angels that should recover soon. 
Via InvestorPlace
Pfizer-BioNTech's COVID-19 Vaccine Shows 100% Effectiveness In Long Term Analysis In Adolescents
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have announced topline results from a longer-term analysis of the safety and efficacy of their COVID... 
Via Benzinga
Exposures COVID-19
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
From Pfizer Inc.
Via Business Wire
Covid Stand-out Pfizer’s Albert Bourla Gets My Vote for CEO of the Year
PFE stock has scored a 38% gain in 2021 with a drug Pfizer didn't develop, thanks to the brilliant leadership of CEO Albert Bourla 
Via InvestorPlace
Exposures COVID-19
7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation
These companies either have no exposure to inflation or have strong branding and customer loyalty, enabling them to pass higher costs. 
Via InvestorPlace
Market Briefing For Monday, Nov. 22
Markets are likely to continue their divergent patterns at the new week's start; and usually the market is 'flattish' ahead of Thanksgiving itself. 
Via Talk Markets
The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting... 
Via Talk Markets
Exposures Product Safety
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the... 
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
87 88 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.